FA808: Advanced drug formulation (5 ECTS)

STADS: 3855501

Level
Master's level course

Teaching period
The course is offered in the autumn semester.

Teacher responsible
Email: kuntsche@sdu.dk

Timetable
Group Type Day Time Classroom Weeks Comment
Common I Wednesday 08-10 U146 46
Common I Wednesday 10-12 U154 47
Common I Thursday 08-10 U154 46
H1 TE Wednesday 10-14 *Odense Lokalitet aftales 10 1
H1 TE Wednesday 09-15 *Odense Lokalitet aftales 10 2
H1 TE Wednesday 10-12 U154 46
H1 TE Wednesday 12-14 U30 47
H1 TL Wednesday 09-12 Lab 10 48,50-51
H1 TL Wednesday 13-16 Lab 10 48,50-51
H1 TE Wednesday 12-16 U30 49
H1 TE Thursday 08-10 U156 47
H1 TE Thursday 08-10 U154 49
Show entire timetable
Show personal time table for this course.

Prerequisites:
The courses Drug formulation and production (FA502, FA503 and FA504) at bachelor pharmacy must be passed.

Academic preconditions:
The Drug Transport and Drug Delivery Systems should have been followed.

Course introduction
The aim of the course is to deepen theoretical and experimental aspects of modern advanced drug formulation to optimize the therapeutic efficiency of drug therapy. The course will provide the students and deeper understanding of advanced formulation strategies with respect on both formulation development and marketed medicines.

The aim of the course is to deepen theoretical and experimental aspects of modern advanced drug formulation to optimize the therapeutic efficiency of drug therapy. The course will provide the students and deeper understanding of advanced formulation strategies with respect on both formulation development and marketed medicines. The course will thus contribute providing the students with competences which are needed for a pharmacist to perform in the area of drug formulation development as well as consulting clinical professionals on new medicines. 
 
The course builds on the knowledge acquired during the bachelor in pharmacy (especially courses in Drug Formulation and Production [FA 502, FA 503 and FA 504] and the course Drug Transport and Drug Delivery Systems at master level.

In relation to the competence profile, the explicit focus of the course is:
  • to provide knowledge and understanding of advanced drug formulation for at optimize the therapeutic efficiency of drug therapy, especially focusing on improvement bioavailability after oral administration, controlled drug release and drug targeting.
  • to train skills in manufacturing and characterization of advanced dosage forms (such as nano- and microparticulate dispersions, self-emulsifying formulations, solid dispersions), in searching and evaluation of scientific literature and in discussing professional issues.
  • to provide competences in critical and problem-oriented assessment and discussion of advanced dosage forms with respect on both formulation development and marketed medicines.
 


Expected learning outcome
The learning objectives of the course is that the student demonstrates the ability:
  • to apply relevant physicochemical terms and principles in drug formulation
  • to explain relevant biopharmaceutical and therapeutic questions in relation to drug formulation
  • to use relevant databases for searching the scientific literature and professional information
  • to discuss marketed advanced medicines and advanced formulation principles in drug development
  • to analyze and discuss experimental results
  • to present theoretical contexts and experimental results in both oral and written form
 


Subject overview
The following main topics are included in the course:

  • parenteral depot formulations (microparticles, in-situ forming implants)
  • nanoparticulate drug formulations for intravenous administration (liposomes, fat emulsions, nanoparticles) incl. drug targeting principles
  • formulation principles of oral medicines with improved bioavailability of critical drug compounds (self-emulsifying formulations, solid dispersions and nanocrystals)
  • formulation and manufacturing principles of selected above-mentioned drug formulations
  • selected analytical methods to characterize the above-mentioned drug formulations (such as microscopy, UV/Vis spectroscopy, particle size analysis, X-ray diffraction, thermal analysis)
Literature
  • P.J. Sinko: Martin’s Physical Pharmacy and Pharmaceutical Sciences, 7th edition, Wolters Kluwer.
  • Yderligere undervisningsmaterialer lægges på E-Learn.


Website
This course uses e-learn (blackboard).

Prerequisites for participating in the exam
None

Assessment and marking:


Expected working hours
The teaching method is based on three phase model.
Intro phase: 6 hours
Skills training phase: 40 hours, hereof:
 - Tutorials: 22 hours
 - Laboratory exercises: 18 hours

Educational activities
  • self-study and after work of topics from the lectures
  • literature search and evaluation
  • analysis of results from the laboratory exercises
  • preparation of a presentation of a selected topic
  • report writing
 
Educational form
The intro phase consists of lectures providing a short introduction into the central topics of the course.

The training phase provides competences within the central topics of the course. During the seminars, the students will work in small groups on a selected topic (theoretical project) and results of the laboratory exercises will be discussed. I the lab exercises, selected experiments and tests within the central topics of course will be performed.

During the study phase, the students will independently work with the literature to obtain and deepen the central topics of the course. Moreover, the students will recapitulate the tasks from the training phase (writing of reports, work on the theoretical projects) and prepare the final presentation of the theoretical project.
 


Language
This course is taught in Danish or English, depending on the lecturer.

Course enrollment
See deadline of enrolment.

Tuition fees for single courses
See fees for single courses.